A Safety and Immunogenicity Study of a Single Dose of a Meningococcal (Groups A, C, W, and Y) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (MEN-ACWY-D) in Healthy Japanese Participants-Reference-Cited by-同舟云学术

A Safety and Immunogenicity Study of a Single Dose of a Meningococcal (Groups A, C, W, and Y) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (MEN-ACWY-D) in Healthy Japanese Participants

Published:2018-11-30 Issue:6 Volume:71 Page:402-407
ISSN:1344-6304
Container-title:Japanese Journal of Infectious Diseases
language:en
Short-container-title:Jpn J Infect Dis

Author:

Fukushima Shinji¹,Kikuchi Hitoshi²,Miyazu Mitsunobu²,Hamada Atsuo¹,Ouchi Kazunobu³,Takagi Hiroki⁴,Mihara Hanako⁴,Sasaki Toru⁴,Oka Hayato⁴,Bosch-Castells Valerie⁵,Oster Philipp⁵

Affiliation:

1. Tokyo Medical University Hospital

2. Meitetsu Hospital

3. Kawasaki Medical School

4. Sanofi K. K.

5. Sanofi Pasteur

Publisher

Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

https://www.jstage.jst.go.jp/article/yoken/71/6/71_JJID.2017.277/_pdf

Reference31 articles.

1. 1. National Institute of Infectious Diseases and Tuberculosis and Infectious Diseases Control Division, Ministry of Health, Labour and Welfare, Japan. Meningococcal infection, 2005-October 2013, Japan. Infect Agents Surveillance Rep. 2013;34:361'-2'.

2. 2. National Institute of Infectious Diseases and Tuberculosis and Infectious Diseases Control Division, Ministry of Health, Labour and Welfare, Japan. Trends in invasive meningococcal disease, week 13, 2013 to week 52, 2014, Japan. Infectious Agents Surveillance Report. 2015;36:179-81. Japanese.

3. 3. Harrison LH. Prospects for vaccine prevention of meningococcal infection. Clin Microbiol Rev. 2006;19:142-64.

4. 4. Keyserling H, Papa T, Koranyi K, et al. Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents. Arch Pediatr Adolesc Med. 2005;159:907-13.

5. 5. Pichichero M, Papa T, Blatter M, et al. Immune memory in children previously vaccinated with an experimental quadrivalent meningococcal polysaccharide diphtheria toxoid conjugate vaccine. Pediatr Infect Dis J. 2006;25:995-1000.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in Adult and Elderly Vaccination: Focus on Vaccination Practices in Tunisia and Morocco;Frontiers in Public Health;2022-07-01

2. Health care professionals’ preference for a fully liquid, ready-to-use hexavalent vaccine in Spain;Preventive Medicine Reports;2021-06

3. Immunogenicity and Safety of a Two-Dose Series of a Meningococcal (Groups A, C, W, and Y) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Men-ACWY-D) in Healthy Japanese Adults;Japanese Journal of Infectious Diseases;2021-05-31

4. Post-Marketing Surveillance Observational Study of Quadrivalent Meningococcal Diphtheria Toxoid Conjugate Vaccine (MenACWY-DT, MCV4/Menactra®) in the Republic of Korea, 2014–2019;Infectious Diseases and Therapy;2021-01-13

5. Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020;MMWR. Recommendations and Reports;2020-09-25